Advanced Therapies
Blood & Organ Banks · Pennsylvania, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
4751 League Island Blvd, Philadelphia, P...Phone Number
(952) 475-2508Website
www.advancedtherapies.comRevenue
$62.4 MillionIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
4
3
5
3
About Advanced Therapies
WuXi Advanced Therapies is a leading global contract testing, development, and manufacturing organization (CTDMO) specializing in the discovery, development, testing, and commercialization of cell and gene therapies. Their comprehensive services include process development, clinical and commercial manufacturing, and analytical testing, aimed at accelerating therapeutic advancements for clients worldwide. With a robust infrastructure and a team of over 1,200 experts, WuXi Advanced Therapies provides tailored solutions for various modalities, including CAR-T, T-Cell therapies, and monoclonal antibodies. Their mission is to leverage global capabilities to improve market access and facilitate groundbreaking treatments for patients.Explore more
Advanced Therapies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Advanced Therapies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Advanced Therapies, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Advanced Therapies launches new products
Check if Advanced Therapies has recently received funding, and reach out quickly before it becomes old news!
Click to see if Advanced Therapies had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Advanced Therapies
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Advanced Therapies has new funding data
Earning: See what the market has to say on Advanced Therapies recently announced quarterly report
Check out if Advanced Therapies is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Advanced Therapies
Compare insights from companies similar to Advanced Therapies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Advanced Therapies
$62.4M
201-500
Private
-
2004
II
Issam IsmailiDirector, Clinical Manufacturing Operations Cell & Gene Therapy
Company Profile Activity
Activity Insights
Advanced Therapies is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Advanced Therapies is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Advanced Therapies.
Advanced Therapies Tech Stack
A closer look at the technologies used by Advanced Therapies
Most Recent Scoops
Event
Product Marketing, Events, Logistics / Supply Chain, Bioengineering, Medical Research, Pharmaceuticals, Healthcare Technology, Manufacturing Operations
Pain Point
Project
An internal source in Operations Management has indicated that the organization is planning to remediate challenges related to distribution and fulfillment operations.
Logistics / Supply Chain
Pain Point
Project
An internal source in Operations Management has indicated that the organization is planning to remediate challenges related to customer support systems.
Enterprise Software, Software, Customer Service
Project
An internal source in Operations Management has indicated that the organization has completed initiatives related to digital transformation within the last nine months.
Upgrade, Digital Technology
Pain Point
Project
Asset Management, Enterprise Software, Software
Advanced Therapies News & Media
WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma
AMTAGVI is the first and only one-time, individualized T cell therapy to receive U.S. FDA approval for a solid tumor cancer. PHILADELPHIA, Feb. 20, 2024 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced that the U.S. Food and Drug Administration (FDA) has approved its Philadelphia site to begin the analytical testing and manufacturing of AMTAGVI for Iovance, which received FDA accelerated approval of its Biologics License Application (BWuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology
PHILADELPHIA, Aug. 11, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced a licensing agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson ("Janssen"). Under this agreement,...ViGeneron and WuXi Advanced Therapies Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy
PHILADELPHIA and MUNICH, Dec. 1, 2020 /PRNewswire/ -- ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. (WuXi ATU), a leading Contract, Testing, Development and Manufacturing Organization (CTDMO), today announced a strategic partnership to accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy program. ViGeneron's innovative gene therapy pipeline addresses ophthalmic diseases with high unmet medical needs. Its lead product VG901 tWuXi Advanced Therapies Expands Philadelphia Campus with New State-of-The-Art Testing Laboratory
PHILADELPHIA, Nov. 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a business unit of WuXi AppTec offering end-to-end contract services for the cell and gene therapies industry – today announced the completion of a facility expansion that will triple its advanced...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Advanced Therapies
Sign Up For FreeTo access detailed company insights
WuXi Advanced Therapies is a leading global contract testing, development, and manufacturing organization (CTDMO) specializing in the discovery, development, testing, and commercialization of cell and gene therapies. Their comprehensive services include process development, clinical and commercial manufacturing, and analytical testing, aimed at acc... Read More
